Catalyst Wire Dossier Catalyst Wire Dossier

Tezampanel

tezampanel · Proniras Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tezampanel, covering 2007-12-04 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder [Phase 1]

See pricing